Hematogenix Pharma Services: Hematogenix introduces companion diagnostic immuno─oncology test for triple─negative breast cancer
Hematogenix, a global leader in the field of integrated pathology services for drug development and immuno─oncology testing
Read full article »
CEO
Hytham Al-Masri
Hematogenix provides molecular tumor profiling, flow cytometry, cytogenetics, molecular diagnostics, bone marrow morphology solutions.
Read more